2nd Rare CNS and Neurodevelopmental Drug Development Summit

Kongressthemen
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.

The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832

Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.

https://go.evvnt.com/1289306-2?pid=4832

Frau Emily Lincoln